Pharmacogenomics and lung transplantation: clinical implications

Pharmacogenomics J. 2006 Sep-Oct;6(5):301-10. doi: 10.1038/sj.tpj.6500376. Epub 2006 Mar 7.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Algorithms
  • Biological Availability
  • Biomarkers / blood
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme System / genetics
  • Cytochrome P-450 Enzyme System / metabolism
  • Drug Monitoring
  • Drug Resistance
  • Gene Expression Profiling*
  • Graft Rejection / blood
  • Graft Rejection / genetics*
  • Graft Rejection / metabolism
  • Graft Rejection / prevention & control
  • Heart Transplantation
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / pharmacokinetics*
  • Lung Transplantation*
  • Organic Anion Transporters / genetics
  • Organic Anion Transporters / metabolism
  • Pharmacogenetics*
  • Polymorphism, Genetic
  • Practice Guidelines as Topic
  • Tacrolimus / adverse effects
  • Tacrolimus / pharmacokinetics
  • Treatment Outcome

Substances

  • ABCB1 protein, human
  • ATP Binding Cassette Transporter, Subfamily B
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Biomarkers
  • Immunosuppressive Agents
  • Organic Anion Transporters
  • Cytochrome P-450 Enzyme System
  • CYP3A5 protein, human
  • Cytochrome P-450 CYP3A
  • Tacrolimus